Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study

Andrea Kuemmerle, Caecilia Schmid, Sonja Bernhard, Victor Kande, Wilfried Mutombo, Medard Ilunga, Ismael Lumpungu, Sylvain Mutanda, Pathou Nganzobo, Digas Ngolo Tete, Mays Kisala, Christian Burri, Severine Blesson, Olaf Valverde Mordt

Open source

DOI: 10.1371/journal.pntd.0009903
Published: 2021-11-08
Container: PLOS Neglected Tropical Diseases
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pntd.0009903,
  title = {Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study},
  author = {Andrea Kuemmerle and Caecilia Schmid and Sonja Bernhard and Victor Kande and Wilfried Mutombo and Medard Ilunga and Ismael Lumpungu and Sylvain Mutanda and Pathou Nganzobo and Digas Ngolo Tete and Mays Kisala and Christian Burri and Severine Blesson and Olaf Valverde Mordt},
  year = {2021},
  journal = {PLOS Neglected Tropical Diseases},
  doi = {10.1371/journal.pntd.0009903},
  url = {https://doi.org/10.1371/journal.pntd.0009903}
}

RIS

TY  - JOUR
TI  - Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study
AU  - Andrea Kuemmerle
AU  - Caecilia Schmid
AU  - Sonja Bernhard
AU  - Victor Kande
AU  - Wilfried Mutombo
AU  - Medard Ilunga
AU  - Ismael Lumpungu
AU  - Sylvain Mutanda
AU  - Pathou Nganzobo
AU  - Digas Ngolo Tete
AU  - Mays Kisala
AU  - Christian Burri
AU  - Severine Blesson
AU  - Olaf Valverde Mordt
PY  - 2021
JO  - PLOS Neglected Tropical Diseases
DO  - 10.1371/journal.pntd.0009903
UR  - https://doi.org/10.1371/journal.pntd.0009903
ER  -

APA

Kuemmerle, A., Schmid, C., Bernhard, S., Kande, V., Mutombo, W., Ilunga, M., Lumpungu, I., Mutanda, S., Nganzobo, P., Tete, D. N., Kisala, M., Burri, C., Blesson, S., & Mordt, O. V. (2021). Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0009903

Source records

crossref · retrieved 2026-09-26T10:04:26.071Z